Announcements Trials
Browse Landscape

Status

Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Observational 1

Sponsor

Cancer Type

Breast 5Genitourinary 3Gastrointestinal 2Thoracic 1Sarcoma 1Plasma cell 1Other hematologic neoplasm 1Lymphoid 1

Conditions

Multiple Myeloma 927Lymphoma 112Recurrence 94Neoplasms, Plasma Cell 92Lymphoma, Non-Hodgkin 67Immunoglobulin Light-chain Amyloidosis 60Hematologic Neoplasms 60Neoplasms 54Smoldering Multiple Myeloma 51Leukemia, Myeloid, Acute 51Leukemia 51Myelodysplastic Syndromes 47Leukemia, Lymphocytic, Chronic, B-Cell 45Precursor Cell Lymphoblastic Leukemia-Lymphoma 38Hodgkin Disease 37Leukemia, Plasma Cell 26Myeloproliferative Disorders 24Monoclonal Gammopathy of Undetermined Significance 23Lymphoma, Large B-Cell, Diffuse 23Lymphoma, Mantle-Cell 22Leukemia, Myelogenous, Chronic, BCR-ABL Positive 22Breast Neoplasms 22Amyloidosis 22Primary Myelofibrosis 21Lymphoma, Follicular 21Waldenstrom Macroglobulinemia 20Ovarian Neoplasms 18Lymphoma, B-Cell, Marginal Zone 17Lymphoma, B-Cell 17Colorectal Neoplasms 16

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Patient Participation × Plasma cell × 1 year × Clear all
NCT05673083 2025-09-04

Impact of a Health Technology Intervention on Patient Activation in Multiple Myeloma

All4Cure

Active not recruiting
200 enrolled
Plasma cell

Multiple Myeloma, Patient Participation

Data powered by HemOnc (CC BY 4.0) Colophon âš¡